Therapeutic Area market research reports by DelveInsight

• Urinary Incontinence - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Urinary Incontinence - Pipeline Insight, 2024 Urinary Incontinence Overview ""Urinary Incontinence Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Urinary Incontinence market. A detailed picture o ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the Total Diagnosed Prevalent Cases of Fuchs Endothelial Corneal Dystrophy (FECD) in the 7MM were ~18.9 million in 2022 and these cases are going to increase during the forec ... Read More

• Acute Lung Injury - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lung Injury - Pipeline Insight, 2024 Acute Lung Injury Overview ""Acute Lung Injury Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Lung Injury market. A detailed picture of the Acute ... Read More

• Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024 Acute Myelogenous Leukemia (AML) Overview ""Acute Myelogenous Leukemia (AML) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Myeloge ... Read More

• Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Juvenile Rheumatoid Arthritis – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Juvenile Rheumatoid Arthritis pipeline landscape. It covers the pipeline drug profiles ... Read More

• Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024 Advanced Cancer Pain Management (ACPM) Overview ""Advanced Cancer Pain Management (ACPM) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

• Rheumatoid Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Rheumatoid Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Rheumatoid Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in Rheumatoid Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and n ... Read More

• Chronic Ocular Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Ocular Pain - Pipeline Insight, 2024 Chronic Ocular Pain Overview ""Chronic Ocular Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Ocular Pain market. A detailed picture of th ... Read More

• Endometriosis Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Endometriosis Pain - Pipeline Insight, 2024 Endometriosis Pain Overview ""Endometriosis Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Endometriosis Pain market. A detailed picture of the En ... Read More

• Androgenetic Alopecia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Androgenetic Alopecia - Pipeline Insight, 2024 DelveInsight’s, “Androgenetic Alopecia – Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Androgenetic Alopecia pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More

• Anaplastic Thyroid Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Thyroid Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Thyroid Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Age Related Macular Degeneration - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Age Related Macular Degeneration - Pipeline Insight, 2024 Age Related Macular Degeneration Overview ""Age Related Macular Degeneration Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age Related M ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalent cases of schizophrenia are projected to increase during the forecast period (2023–2034) due to the rising awareness regarding mental illness and improvements in diagnosis ... Read More

• Schizophrenia - Epidemiology Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Schizophrenia - Epidemiology Forecast - 2034 DelveInsight’s ‘Schizophrenia – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of schizophrenia, historical and forecasted epidemiology, as well as the trends in the United States, EU4 (Germany, France, Italy, and Spain), and the ... Read More

• Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Anal cancer is relatively uncommon, accounting for about 2.7% of all reported gastrointestinal cancers in the United States. Anal cancer is more prevalent among women than men and is most frequently diagnosed betwee ... Read More

• Schizophrenia Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Schizophrenia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of cervical dystonia is projected to increase during the forecast period (2023–2034). This increase is attributed to heightened awareness among healthcare professionals and the general public regardin ... Read More

• Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The US accounted for the largest market size of cervical cancer, i.e., nearly USD 530 million in 2023. Cervical cancer is most often diagnosed between the ages of 35 and 44. The average age of diagnosis in the U ... Read More

• Dry Eye Disease - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Dry Eye Disease - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Restrictive Cardiomyopathy market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Restrictive Cardiomyopathy in the 7MM is expected to increase, drive ... Read More

• Complicated Urinary Tract Infections Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Complicated Urinary Tract Infections Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Lymphomas are cancers that originate in the lymphatic system, specifically from a type of white blood cell called a lymphocyte.Lymphocytes can be further sub-divided into B cells, T cells and ... Read More

• Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In 2021, the market size of ALL in the 7MM was app ... Read More

• Complicated Urinary Tract Infections - Epidemiology Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Complicated Urinary Tract Infections - Epidemiology Forecast - 2034 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyeloneph ... Read More

• CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More

• Down Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Down Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the total market size of Peripheral Nerve Injuries accounted for ~USD 2.4 billion in the 7MM. In 2023, annual number of peripheral number injuries of upper extremities in the 7MM were ~2.9 million and of ... Read More

• Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Malignant ascites (MA) is a pathological condition due to a variety of primary abdominal and extra-abdominal neoplasms. It is a primary cause of morbidity and presents many difficulties and t ... Read More

• Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of wAIHA was ~ USD 300 million. wAIHA is the most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric ... Read More

< prev 16 17 18 19 20 21 22 23 24 25 next >